X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (34) 34
humans (29) 29
female (26) 26
male (25) 25
multiple sclerosis (23) 23
clinical neurology (19) 19
adult (16) 16
middle aged (16) 16
neurosciences (16) 16
disease progression (13) 13
aged (10) 10
neurology (10) 10
patients (10) 10
disability (9) 9
disability evaluation (9) 9
treatment outcome (9) 9
analysis (8) 8
cohort studies (8) 8
medicine & public health (8) 8
neuroradiology (8) 8
care and treatment (7) 7
recurrence (7) 7
young adult (7) 7
age of onset (6) 6
multiple sclerosis - epidemiology (6) 6
multiple sclerosis, relapsing-remitting - drug therapy (6) 6
prognosis (6) 6
risk factors (6) 6
abridged index medicus (5) 5
diagnostic-criteria (5) 5
guidelines (5) 5
motion picture directors & producers (5) 5
prevalence (5) 5
prospective studies (5) 5
psychiatry (5) 5
risk (5) 5
surgery (5) 5
women (5) 5
adolescent (4) 4
alemtuzumab (4) 4
astrophysics (4) 4
clinical trials (4) 4
disease (4) 4
dk/atira/pure/researchoutput/pubmedpublicationtype/d016428 (4) 4
epidemiology (4) 4
health aspects (4) 4
natural-history (4) 4
population (4) 4
survival analysis (4) 4
wales (4) 4
aged, 80 and over (3) 3
alemtuzumab - therapeutic use (3) 3
competition (3) 3
complement (3) 3
development and progression (3) 3
diagnosis (3) 3
economics (3) 3
feminism (3) 3
follow-up studies (3) 3
galaxy: evolution (3) 3
immunosuppressive agents - therapeutic use (3) 3
independence movements (3) 3
inflammation (3) 3
journal club (3) 3
knightley, keira (3) 3
milky way (3) 3
monoclonal antibodies (3) 3
multidisciplinary sciences (3) 3
multiple sclerosis - psychology (3) 3
multiple sclerosis, relapsing-remitting - physiopathology (3) 3
oppression (3) 3
outcomes (3) 3
physics (3) 3
relapses (3) 3
research (3) 3
retrospective studies (3) 3
self expression (3) 3
stars (3) 3
therapy (3) 3
time factors (3) 3
wales - epidemiology (3) 3
[ phys.astr.co ] physics [physics]/astrophysics [astro-ph]/cosmology and extra-galactic astrophysics [astro-ph.co] (2) 2
[ sdu.astr.co ] sciences of the universe [physics]/astrophysics [astro-ph]/cosmology and extra-galactic astrophysics [astro-ph.co] (2) 2
abundance (2) 2
activation (2) 2
actors (2) 2
age factors (2) 2
algorithms (2) 2
antibodies (2) 2
area under curve (2) 2
association (2) 2
astronomy & astrophysics (2) 2
astrophysics - astrophysics of galaxies (2) 2
astrophysics, cosmology and astronomy (2) 2
autoimmunity (2) 2
autoimmunity - drug effects (2) 2
biomarker (2) 2
biomarkers (2) 2
biomarkers - blood (2) 2
chemical evolution (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 949 - 956
Summary Background Diffuse-type tenosynovial giant cell tumour (dt-GCT) of the soft tissue (alternatively known as pigmented villonodular synovitis), an orphan... 
Hematology, Oncology and Palliative Medicine | PIGMENTED VILLONODULAR SYNOVITIS | DIAGNOSIS | THERAPY | EFFICACY | ONCOLOGY | PERIORBITAL EDEMA SECONDARY | MACROPHAGES | RECEPTOR | ANTIBODY | ARTHRITIS | IMATINIB MESYLATE | Receptor, Macrophage Colony-Stimulating Factor - antagonists & inhibitors | Receptor, Macrophage Colony-Stimulating Factor - immunology | Giant Cell Tumors - immunology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Giant Cell Tumors - pathology | Soft Tissue Neoplasms - drug therapy | Male | Antineoplastic Agents - administration & dosage | Giant Cell Tumors - metabolism | Receptor, Macrophage Colony-Stimulating Factor - metabolism | Synovitis, Pigmented Villonodular - drug therapy | Synovitis, Pigmented Villonodular - pathology | Soft Tissue Neoplasms - immunology | Young Adult | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Drug Administration Schedule | Soft Tissue Neoplasms - metabolism | Synovitis, Pigmented Villonodular - metabolism | Treatment Outcome | Synovitis, Pigmented Villonodular - immunology | Giant Cell Tumors - drug therapy | Signal Transduction - drug effects | Antibodies, Monoclonal - administration & dosage | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Infusions, Intravenous | Monoclonal antibodies | Macrophage colony stimulating factor | Tumors
Journal Article
Journal of Neurology, ISSN 0340-5354, 1/2019, Volume 266, Issue 1, pp. 278 - 280
...Journal of Neurology (2019) 266:278–280 https://doi.org/10.1007/s00415-018-9128-9 JOURNAL CLUB New rare genetic variants in multiple sclerosis Katharine E... 
Neurology | Neurosciences | Medicine & Public Health | Neuroradiology | CLINICAL NEUROLOGY | Genetic variance | Multiple sclerosis | Journal Club
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2019, Volume 321, Issue 2, pp. 175 - 187
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 11/2018, Volume 24, Issue 13, pp. 1786 - 1787
Journal Article
Journal of neurology, ISSN 0340-5354, 05/2016, Volume 263, Issue 5, pp. 1045 - 1046
Journal Article
Journal of Neurology, ISSN 0340-5354, 5/2016, Volume 263, Issue 5, pp. 1045 - 1046
...J Neurol (2016) 263:1045–1046 DOI 10.1007/s00415-016-8137-9 JOURNAL CLUB Deep brain stimulation for dystonia Katharine E. Harding 1 • Neil P. Robertson 1... 
Neurology | Neurosciences | Medicine & Public Health | Neuroradiology | CLINICAL NEUROLOGY
Journal Article
Brain Pathology, ISSN 1015-6305, 07/2018, Volume 28, Issue 4, pp. 507 - 520
The complement pathway has potential contributions to both white (WM) and grey matter (GM) pathology in Multiple Sclerosis (MS). A quantitative assessment of... 
immunohistochemistry | complement | tissue microarray | multiple sclerosis | SYSTEM | FACTOR-H | PATHOLOGY | BLOOD-BRAIN-BARRIER | NEUROSCIENCES | CLINICAL NEUROLOGY | PATHOGENESIS | MICROGLIA | INFLAMMATION | DISEASE | EXPRESSION | DEMYELINATING LESIONS | Immunohistochemistry | Neurons - pathology | Complement Activation | Kidney - pathology | Humans | Middle Aged | Astrocytes - pathology | Kidney - immunology | Male | Tissue Array Analysis - methods | White Matter - immunology | Microglia - immunology | Astrocytes - immunology | Microglia - pathology | Adult | Female | Gray Matter - immunology | Neurons - immunology | White Matter - pathology | Gray Matter - pathology | Brain - pathology | Multiple Sclerosis - immunology | Multiple Sclerosis - pathology | Aged | Brain - immunology | Viral antibodies | Fibrin | Multiple sclerosis | Analysis | Fibrinogen | Antibodies | Methods | Complement receptors | Regulators | Complement component C3b | Methodology | Complement component C5a | Activation | Complement | Substantia grisea | Clusterin | Proteins | Complement factor H | Lesions | Localization | Quantitative analysis | Neurons | Glial fibrillary acidic protein | Cortex | Complement regulatory proteins | Complement component C1 | Complement component C1q | Pathology | Complement activation | Biomarkers | Digitization | Histocompatibility antigen HLA
Journal Article
Neurology, ISSN 0028-3878, 03/2019, Volume 92, Issue 13, pp. e1497 - e1506
OBJECTIVETo examine the association between socioeconomic status (SES) and disability outcomes and progression in multiple sclerosis (MS). METHODSHealth... 
MORTALITY | DEPRIVATION | DISEASE | RISK | SMOKING | EDUCATION | LEVEL | NATURAL-HISTORY | GRADIENT | CLINICAL NEUROLOGY | COMORBIDITY | Prognosis | Prospective Studies | Humans | Middle Aged | Proportional Hazards Models | Wales | Male | British Columbia | Disease Progression | Social Class | Young Adult | Multiple Sclerosis - physiopathology | Adult | Female
Journal Article